Vitamin D and metabolic, autoimmunologic and neoplasm diseases

Karolina Galant; Ewa Barg; Bernarda Kazanowska

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

1/2016
vol. 22

Send email

Copy url:

abstract:

Review paper

Vitamin D and metabolic, autoimmunologic and neoplasm diseases

Karolina Galant

,

Ewa Barg

,

Bernarda Kazanowska

Pediatr Endocrinol Diabetes Metab 2016;24,1:32-38

Online publish date: 2017/01/26

View full text Get citation

At the turn of the 19th and 20th century McColum made the discovery of vitamin D as a result of the research on cod liver oil, in order to identify substances having anti ricets effect. Since that time, knowledge of its role in the human body systematically increases. For many years it was thought that it only plays a role in regulating calcium economy. The discovery in the mid-1970s of the presence of VDR- Vitamin D Receptor in most cells of the human body have turned attention to its pleiotropic effect. Special attention deserves wit. D impact on the risk of metabolic diseases and of pre-neoplasia as well as the long-term effects of the treatment of these diseases. The article presents a short review of the results of previously conducted studies on these issues.

keywords:

Vitamin D and metabolic, autoimmunologic and neoplasm diseases

Karolina Galant , Ewa Barg , Bernarda Kazanowska

vitamin D, metabolic diseases, neoplasia diseases, vitamin D receptor

Karolina Galant

,

Ewa Barg

,

Bernarda Kazanowska